Triheptanoin
Pro00103582
Phase 1 small_molecule completed
Quick answer
Triheptanoin for Glycogen Storage Disease Type I is a Phase 1 program (small_molecule) at Ultragenyx UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx UK Limited
- Indication
- Glycogen Storage Disease Type I
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed